Open AccessP831: PATIENT‐REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL
Author(s) -
Röth A.,
Panse J.,
Gentile B.,
Buri M.,
Patel H.,
Nagy Z.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846208.84566.a3
Subject(s) - paroxysmal nocturnal hemoglobinuria , medicine , eculizumab , quality of life (healthcare) , anemia , hemoglobinuria , clinical trial , physical therapy , pediatrics , antibody , immunology , nursing , complement system